Latest/Other News
Lipoedema: What We Know Now - A Blog Post
By Mary Fickling on Nov 06 2025.
For millions of women, the experience of "stubborn fat"—areas that refuse to shrink despite diligent diet and exercise—is a source of deep frustration. It's often dismissed as a simple lack of willpower or a genetic predisposition to carry weight in certain areas. However, for a significant percentage of this population, the underlying cause is not a lifestyle issue but a distinct and frequently misdiagnosed medical condition: lipoedema.
Lipedema and adipose tissue: current understanding, controversies, and future directions
By Mary Fickling on Nov 06 2025.
MINI REVIEW article - Front. Cell Dev. Biol., 06 November 2025 Sec. Molecular and Cellular Pathology Volume 13 - 2025 | https://doi.org/10.3389/fcell.2025.1691161
DEEP OSCILLATION® Now Transforming Speech Therapy
By Mary Fickling on Nov 06 2025.
From Practice for Practice:
Experiences with DEEP OSCILLATION in speech therapy
A Gentle Approach to Healing in a Puppy
By Mary Fickling on Nov 04 2025.
By Christine Talbot, Lymphoedema, Bowen and DEEP OSCILLATION® Practitioner
The Missing Piece of The Puzzle - DEEP OSCILLATION
By Mary Fickling on Oct 27 2025.
By Vaida Voitechovic
The Efficacy and Safety of Deep Oscillation in the Management of Post-Mastectomy Pain Syndrome: A Case Series
By Mary Fickling on Oct 16 2025.
Presented by Lic. Rosario Pineda at the XXI World Congress of the International Union of Phlebology (UIP) in Buenos Aires in 2025. A prestigious event for professionals in the fields of phlebology and lymphology.
On London Daily News: Physiopod UK launches national survey to bridge critical evidence gaps in head and neck lymphoedema care
By Mary Fickling on Oct 13 2025.
PhysioPod® UK Limited, the exclusive supplier of DEEP OSCILLATION®, has announced the launch of a comprehensive national survey initiative titled “UK Treatments & Experiences of Head & Neck Lymphoedema (HNL)“. This initiative aims to collect robust data from both patients and healthcare professionals (HCPs) to illuminate significant challenges in Head and Neck Lymphoedema (HNL) management and demonstrate the potential of Deep Oscillation Therapy (DOT) as a cost-effective solution for the NHS.
DEEP OSCILLATION THERAPY ENHANCES EARLY REHABILITATION AFTER ACL RECONSTRUCTION: A RANDOMIZED CONTROLLED TRIAL
By Mary Fickling on Oct 12 2025.
Oestervemb, Katarzyna & Trybulski, Robert & Szczygie?, El?bieta & Szczygielska-Babiuch, Anna & Kacprzak, Bart?omiej & Hagner–Drengowska, Magdalena. (2025). Deep oscillation therapy enhances early rehabilitation after ACL reconstruction: a randomized controlled trial. Journal of Rehabilitation Medicine. 57. jrm44416. 10.2340/jrm.v57.44416.
A Personal Experience of Breast Cancer Related Lymphoedema: Deep Oscillation Achieves & Maintains Major Reduction in Limb Size and Eliminates Cellulitis Episodes
By Mary Fickling on Oct 10 2025.
October is recognised globally as Breast Cancer Awareness Month, a month for us all to come together and raise awareness of this devastating disease and its impact.
Clinical Case Report: Multimodal Therapy for Severe Head and Neck Lymphoedema and Fibrosis Driven by Deep Oscillation
By Mary Fickling on Oct 08 2025.
Head and Neck Lymphoedema (HNL) with severe fibrosis affects up to 90% of those treated for Head and Neck Cancer (HNC). This report from Lila Hipwell-Larken BSc, details multimodal therapy, using Deep Oscillation Therapy (DOT) as a crucial adjunct for patient HMTTC. DOT drove rapid reduction in oedema, pain, and fibrosis, resulting in significant improvements in function and Quality of Life (QoL)

